Group Leader at EMBL Barcelona. Malaria, bioengineered vascular models, blood-brain barrier
Maria Bernabeu
📣Announcing the 4th edition of the EMBL‑IBEC Conference on “Engineering Multicellular Systems”, taking place 11–13 March 2026 in Barcelona. Exploring organoids, mechanobiology, embryo models, organ-on-chip systems, multiomics and more. Abstracts open now!
events.ibecbarcelona.eu/embl-ibec-co...
Huge thanks to @mariabernabeu.bsky.social and to everyone else who contributed and made this project possible 🎉
I’ve been in Toronto at the #astmh meeting these past few days and last night some very good news was presented here: A new malaria drug has proven efficacious in a large trial and could soon be approved.🧪
My story in @science.org (and 🧵on why it's important to come):
www.science.org/content/arti...
Come to Biomalpar xxii!!! We have an outstanding line up of speakers!!!
It is a true honor to be an organizer of Biomalpar. It was the first conference I ever attended during my 2nd PhD year so it feels special.
And don't miss the beautiful poster image from Hannah Fleckenstein!
Thanks for the support of @caixaresearch.bsky.social to continue our efforts to use tissue engineering to study cerebral malaria. We will develop stem-cell derived immunocompetent BBB models with microglia to study malaria, in a side by side comparison with spatial transcriptomics in patients.
This will be done in collaboration with Chris Moxon at @uofglasgow.bsky.social and in Blantyre, Malawi. We will also have the support of @epetsalaki.bsky.social at @ebi.embl.org for advanced computational analysis.
Xavier Trepat
Alina Batzilla
Maria Bernabeu
Maria Bernabeu
Kai Kupferschmidt
Maria Bernabeu
www.science.org
As existing drugs falter because of resistance, the world gets a backup—but hard choices loom on how to use it
